Related Experiment Video
Updated: Mar 29, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Emerging Bladder Cancer Biomarkers and Targets of Therapy
George J Netto1, Laura J Tafe2
1Department of Pathology, The Johns Hopkins Medical Institutes, Baltimore, MD, USA; Department of Oncology, The Johns Hopkins Medical Institutes, Baltimore, MD, USA; Department of Urology, The Johns Hopkins Medical Institutes, Baltimore, MD, USA.
Abstract:
Bladder cancer is a heterogeneous disease characterized by complex networks of molecular alterations and gene expression. This review summarizes some of the recent genomic studies that have further advanced the understanding of the pathways driving bladder cancer, highlighting several important biomarkers and potential targeted therapeutic strategies that are now in clinical trials. In addition, noninvasive techniques to evaluate biomarkers in patients' urine and serum for early detection and surveillance are discussed.
Insights
This review covers recent genomic studies on bladder cancer, identifying key biomarkers and targeted therapies. It also discusses noninvasive urine and serum tests for early detection and monitoring.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Bladder cancer is a complex disease with diverse molecular changes.
- Understanding these alterations is crucial for developing effective treatments.
Purpose of the Study:
- To review recent genomic studies on bladder cancer pathways.
- To highlight key biomarkers and targeted therapies in clinical trials.
- To discuss noninvasive biomarker detection methods.
Main Methods:
- Literature review of genomic studies.
- Analysis of biomarker data.
- Discussion of targeted therapeutic strategies.
- Review of noninvasive diagnostic techniques.
Main Results:
- Genomic studies have elucidated key pathways driving bladder cancer.
- Several important biomarkers have been identified.
- Promising targeted therapies are advancing in clinical trials.
- Noninvasive methods for biomarker evaluation show potential.
Conclusions:
- Genomic insights are improving bladder cancer understanding and treatment.
- Biomarkers and targeted therapies offer new avenues for patient care.
- Noninvasive techniques may enhance early detection and surveillance.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies